Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule compound with the formula C21H21N3O5S and a molecular weight of approximately 427.5 g/mol. It is classified as a benzenesulfonate ester and has been referenced in chemical databases as an experimental or candidate drug, but there is no evidence of clinical use, approved indications, or known mechanism of action. No information on its pharmacological activity, therapeutic target, or disease indication is available in public sources[2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate.